Diabetes - Continuous Subcutaneous Insulin Infusion

In addition to tools/resources developed specifically by the PEN® team or its partner associations (see PEN Handout Collections which includes translations and adaptations where available), links to tools/resources on external websites have been selected for this Knowledge Pathway based on their consistency with the evidence, authoritative source and currency. These external tools/resources are provided as sources of additional information believed to be reliable and accurate at the time of publication and should not be considered an endorsement of any information, service, product or company. Country-specific resources may not be totally consistent with the evidence presented in PEN, but are included to reflect current country guidelines and practice.

• Diabetes Canada - Continuous Subcutaneous Insulin Infusion Therapy

  Last Updated: 2022-01-25 – Handout

  Practice guidance section for professionals within the Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada: Glycemic Management in Adults with Type 1 Diabetes about CSII or insulin pump therapy

  Target Audience: Professional

• Diabetes Canada: Technology and Devices

  Last Updated: 2022-01-25 – Handout

  Information from Diabetes Canada for consumers about blood glucose monitors and insulin pumps.

  Target Audience: Consumer